For equity investors, even a hint of suspect governance is a big red flag. It isn#39;t surprising, therefore, that the Aurobindo Pharma stock came under selling pressure on November 10 after it was reported that its Director, P Sarath Chandra Reddy, had been arrested by the Enforcement Directorate.